CatalystWireBeta

Half-year Results

In brief · summary, not quotable

H1 revenue up 10.5% to £23.5m; adjusted profit down 9.4% to £4.0m; >90% full year visibility.

vs expectations: in line

Half year to 31 Mar 2024NowYear beforeChange
Revenue £23.5m £21.3m +10.5%
Operating profit £2.3m £3.5m −33.9%
Profit before tax £3.4m £4.0m −15.5%
Net income £1.4m £3.2m −56.5%
Cash from operations £2.2m £0.4m +477.6%
Net cash / (debt) £54.8m £63.6m −13.8%
Cash £10.8m £11.6m −7.4%

Figures as reported, converted to £ where needed – see all financials.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your OMG notes

Vicon secures seven markerless cornerstone customers to redefine future of motion capture

Industrial Vision Systems, performing well, opening up smart manufacturing opportunities

>90% full year revenue visibility, a growing pipeline and resources for targeted M&A

Oxford Metrics plc (LSE: OMG), the smart sensing and software company, servicing life sciences, entertainment and engineering markets, announces unaudited interim results for the six months ended 31 March 2024.

Commenting on the results Imogen Moorhouse, Chief Executive, said: "Now over halfway into delivering our five-year plan, our teams are in full execution mode. I'm pleased to announce that we are making clear progress both operationally and financially towards our goals, as we report on track first half revenues, demonstrating strong Vicon execution.

Our recent acquisition of Industrial Vision Systems has been a successful move, it's performing well and we are excited about the opportunity to drive yet more applications into the smart manufacturing space. We have the financial resources to do so and are working on a number of interesting M&A opportunities to build out our presence in this growing vertical.

As Vicon works towards commercialising markerless, which enables 3D motion capture without the need to wear motion capture suits or markers, we are working with seven cornerstone customers to make the product the gold standard.

Looking ahead, Oxford Metrics enters the second half with >90% visibility of full year revenues and with a growing pipeline, the Board believes the Group is well placed to deliver results in line with current market expectations."

Continuing OperationsH1 FY24H1 FY23%
Revenue£23.5m£21.3m+10.5%
Adjusted Profit before Tax*£4.0m£4.5m-9.4%
Adjusted* Basic Earnings per Share2.63p2.94p-10.5%
Statutory Profit/(Loss) before Tax£2.8m£3.4m-17.0%
Statutory Basic Earnings per Share2.13p2.59p-17.8%
Dividend paid£3.6m£3.2m+9.0%
Net Cash£54.8m£63.6m-13.9%
H1 FY24FY23H1 FY23
Order Book**£3.0m£11.3m£21.9m

* Profit/(loss) Before Tax from continuing operations before Group recharges adjusted for share-based payments, amortisation of intangibles arising on acquisition and exceptional costs

** FY23 comparative restated at $1.25/£ exchange rate

Financial Highlights

●Headline Group revenue of £23.5m, up 10.5% (H1 FY23: £21.3m).
●Group adjusted profit before tax of £4.0m (H1 FY23: £4.5m), reflecting planned investment in the five-year plan to develop and commercialise markerless.
●Order book of £3.0m (FY23: £11.3m / H1 FY23**: £21.9m), reflecting normalisation of customer buying behaviour post supply chain challenges.
○Strong sales pipeline with >90% visibility on full year revenue.
●Adjusted earnings per share 2.63p (H1 FY23: 2.94p).
●Strong balance sheet with net cash position of £54.8m as at 31 March 2024 (H1 FY23: £63.6m), providing considerable resources to continue pursuing targeted M&A.
●Cash generated by operations of £2.2m (H1 FY23: £0.4m) with cash deployed for working capital purposes to augment inventory and underpin second half performance.
Operational Highlights
First half revenue driven by strong execution
●Vicon's revenue grew 2.2%, at a headline level, to £21.8m (H1 FY23: £21.3m), ( on a constant currency basis underlying growth was 3.3%), driven by Vicon's strong execution.
●Order book returns to more normal levels:
○Vicon customer buying behaviour normalising - a trend we expect to continue.
○Total Order in-take in H1 of £15.0m (H1 FY23: £19.8m).
○Total Orders-in-hand as at 31 March 2024 of £3.0m (FY23: £11.3m / H1 FY23: £21.9m).
●Engineering revenues of £4.8m, up 56.6%.
○Contracts secured for automotive, aerospace and metrology sectors.
○Satellite Applications Catapult is using Vicon to track robots and simulate orbital environments.
●Life Sciences revenues of £8.0m, up 38.3%.
○Valkyrie accreditation with UK Conformity Assessment (UKCA) medical device mark, enabling systems to be delivered to hospitals around the world including:
▪New customers : Hong Kong Children's Hospital, Yamagata University Hospital (Japan), Vinmec International Hospital (Vietnam);
▪Long-standing customers : Guy's & St Thomas' (UK), Shriners Children's Hospital (USA); and
▪The Nuffield Orthopaedic Centre in Oxford, one of Vicon's first-ever customers.
○New Valkyrie customer, University of Sydney
▪Using system for research into head injuries with Rugby League and Rugby Union.
▪Aim to reduce players concussions in the sport.
●Entertainment revenues of £8.5m, down 22.8%, following a very strong FY23 APAC performance that is now seeing delayed effects from the global games industry contraction.
○Valkyrie delivered, through partner Lux Machina, to London College of Fashion and MyWorld, a new global centre of creative technology.
○Paper Games, in China, added an additional large Valkyrie system to add realism to their female-focused games and their VTuber, Nikki.
●Location-based Entertainment (LBE) revenues of £0.4m, down 73.7%, due to delayed partner rollouts that we expect to deliver in H2 FY24.
○Sandbox VR, now operating in over 46 locations in multiple countries.
○New partnership with Apparel Group:
▪Plan to open 25 new locations by 2028;
▪Across the UAE, Kingdom of Saudi Arabia, Qatar, Kuwait, Bahrain and Oman.
○Immersive Gamebox trialling experiences across Merlin Entertainment sites following multi-million pound and multi-territory agreement.
●Markerless becoming a reality and presents a significant opportunity
○Vicon has now partnered with seven cornerstone customers.
○Together we are further developing and testing the technology for commercialisation.
○Cutting-edge advancements will redefine motion capture and content production.
●With our focus firmly on markerless - where we see the largest growth opportunity - we have taken a strategic decision to discontinue IMeasureU (IMU) New Zealand operations.
○Actively engaged in planned discussions to sell the IP.
Smart manufacturing
●Acquisition of Industrial Vision Systems ("IVS") completed and is performing well.
●Delivered revenues of £1.8m in the first half and an orderbook of £1.0m.
●Brings new niche market strength in smart manufacturing.
●High precision, automated quality control used across numerous industries.
●Multiple new contracts secured as demand continues for automated inspection and quality control.
●IVS goes into the second half with a healthy sales pipeline and clear growth opportunities as part of Oxford Metrics.
Outlook
●>90% visibility of full year revenues and a growing sales pipeline ahead of this time last year.
●Deploying resources to actively pursue M&A to build out smart manufacturing and IVS.
●Encouraged by feedback of markerless advancements as our teams and partners work hard to commercialise the offering, optimising the future of motion capture.
●Going forward we do not expect to maintain a significant order book with the return to customer trading patterns consistent with those seen pre-pandemic.
●New CFO designate, Zoe Fox to be appointed Group CFO effective 1 July 2024.
●The Board believes Oxford Metrics is well placed to deliver full year results in line with current market expectations.

Chief Executive's Statement

Now in year three and just over halfway into delivering our five-year plan, the team is in full execution mode, and we are making clear progress towards our goals. Today, we report an on track first half revenue performance, driven by strong Vicon execution.

During the half, we welcomed Industrial Vision Systems into the Group. An earnings enhancing acquisition taking us into a new market - smart manufacturing. We are excited about the opportunities this move brings to extend into yet more applications.

Our team at Vicon has been making good progress commercialising markerless. Markerless will be a key part of the future of our industry, enabling 3D motion capture without the need to wear motion capture suits or markers, using the latest machine learning and AI techniques to process video imagery to create 3D visualisations. As part of our Pioneer Programme to further develop and test the markerless technology, Vicon has now partnered with seven cornerstone customers to get the delivery and commercialisation right and set the gold standard.

In March, after 15 years as our CFO, David Deacon announced his desire to move away from a full-time executive role with these Interims being his last. I would like to take the opportunity to thank David for his years of service. David will remain with the business for a period of time to ensure a smooth handover to our CFO designate, Zoe Fox, who will be appointed as the Group's CFO from 1 July 2024.

As expected, the Vicon business has returned to pre-pandemic trading patterns. Our order book has returned to more normal levels as customer demand and buying behaviours have normalised post the pandemic disruption and the well-documented global supply chain challenges throughout that time. This continues the trend we saw in the second half of FY23 which saw us close the year with orders-in-hand of £11.3m.

As our teams focus their attention and innovation efforts on commercialising markerless - where we see clear growth opportunities - we have taken a strategic decision to discontinue IMeasureU (IMU), our New Zealand operation and are actively engaged in discussions to sell the IP.

On target first half trading

KPIRevenuePBTAdjusted PBT*
H1 FY24H1 FY23H1 FY24H1 FY23H1 FY24H1 FY23
Vicon£21.7m£21.3m£1.9m£3.4m£4.3m£5.4m
IVS£1.8m-£0.3m-£0.5m-
Group--£1.2m£0.6m(£0.8m)(£0.9m)
Continuing£23.5m£21.3m£3.4m£4.0m£4.0m£4.5m
Discontinued£0.0m£0.0m(£1.4m)(£0.1m)(£0.5m)(£0.4m)
Group£23.5m£21.3m£2.0m£3.9m£3.5m£4.1m

The Group reports revenues of £23.5m (H1 FY23: £21.3m), up 10.5% at a headline level. The Group also reports an Adjusted PBT* of £4.0m (H1 FY23: £4.5m), which largely reflects the net effect of increased revenues less planned investment in the five-year plan to develop markerless technology, additional Vicon Sales & Marketing investment, increased property related costs and some inflationary related increases.

Vicon successfully stepped-up volume again, delivering most of the opening order book whilst at the same time booking new orders in the first half of £14.0m. The current Vicon orderbook stands at £2.0m and we expect this to be delivered in the second half.

Our acquisition of IVS was completed and is performing well, reporting revenues of £1.8m and an Adjusted profit of £0.5m in the first half; further, the business has an orderbook of £1.0m and a healthy sales pipeline.

Vertical market segments performance was as follows:

Engineering

Engineering reported revenues of £4.9m (H1 FY23: £3.1m) representing growth of 56.6%.

Common applications for Vicon solutions in the Engineering market include Unmanned Aerial Vehicle (UAV) and robot tracking, robotics development and evaluating product designs in manufacturing, ergonomics and research. Contracts were secured from automotive, aerospace and metrology sectors. Of note is the work being carried out at Satellite Applications Catapult. Catapult added cameras to their existing Vicon system which they use to help them track robots and simulate orbital environments to prepare for servicing, refuelling and assembly operations in space.

Life Sciences

Life Sciences reported revenues of £8.1m (H1 FY23: £5.8m) representing growth of 38.3%. Valkyrie successfully achieved the UK Conformity Assessment (UKCA) medical device mark accreditation, a new and more stringent classification on patient safety and device performance, part of the UK Medical Device Regulations (MDR). This accreditation enabled Valkyrie systems to be delivered to hospitals around the world including:

●New customers , Hong Kong Children's Hospital, Yamagata University Hospital (Japan), Vinmec International Hospital (Vietnam);
●Long-standing customers Guy's & St Thomas's Hospital (UK), Shriners Children's Hospital (USA); and
●The Nuffield Orthopaedic Centre, (UK) one of Vicon's first-ever customers.

Our new customer, University of Sydney, invested in a Valkyrie solution for research into head injuries with Rugby League and Rugby Union players with the aim of studying safer tackling techniques that could reduce the risk of concussions in sport.

Entertainment

Entertainment reported revenues of £8.5m (H1 FY23 £11.0m) representing a decline of 22.8%. This follows a very strong FY23 performance in APAC that is now seeing delayed effects from the global games industry contraction.

Through our customer and partner, Lux Machina, Valkyrie solutions were delivered to London College of Fashion and MyWorld, a new global centre of creative technology. Most recently, Paper Games in China added an additional large Valkyrie system to their existing Valkyrie solution to add realism to their female-focused games and their VTuber, Nikki, who live streams weekly.

Location-based Entertainment (LBE)

LBE reported revenues of £0.4m (H1 FY23: £1.4m) representing a decline of 73.7% due to delayed partner rollouts that we expect to deliver throughout the rest of FY24.

Our partner, Sandbox VR, is now operating in 46 locations in multiple countries and continues to expand. Sandbox VR recently announced it is partnering with Apparel Group and plans on opening 25 new locations across the UAE, Kingdom of Saudi Arabia, Qatar, Kuwait, Bahrain, and Oman by 2028. Elsewhere, our partner Immersive Gamebox is trialling experiences across Merlin Entertainment sites, following its multi-million pound and multi-territory agreement.

Smart manufacturing

Encouragingly, multiple new contracts have been secured in the first half as demand continues for automated inspection and quality control. The medical sector saw the largest growth in the first half, including:

●A leading London hospital invested in a semi-automatic inspection system to verify if particulates are present in fluid filled glass containers that would otherwise contaminate the chemical-based product.
●A new medical client invested in six inspection systems, three units for integration within existing production lines and three high-speed standalone pellet inspection machines.
●Multiple contracts were secured worldwide for inspection systems for high-speed contact lens production lines including an automated inspection system for a new Spanish-based contact lens manufacturer. A new automotive client invested in an automated battery verification end of line solution and a US owned, UK-based aerospace manufacturer invested in our market leading industry 5.0 smart workbench solution for its assembly line.

Overall, Vicon reported a gross margin at 68.7% (H1 FY23: 69.1%) in the first half as anticipated and is attributed to the mix of revenues arising from both the specific geographic spread of revenues and the various margin contributions of each product line. As the residual supply chain costs begin to normalise, together with other initiatives, we expect gross margin to show improvement in the second half.

Given the above revenue and gross margin performance coupled with a rise in the underlying cost base, before Group costs, Vicon reported an Adjusted PBT* of £4.3m (H1 FY23: £5.3m) and an unadjusted profit before tax of £1.9m (H1 FY23: £3.4m) and IVS reported an Adjusted Profit of £0.5m.

Returning to the Balance Sheet, the cash position, having paid a final dividend of £3.6m and deployed £6.2m on the acquisition of IVS in the first half, finished at £54.8m as at 31 March 2024 (H1 FY23: £63.6m). Cash generated by operations during the first half was £2.2m compared with £0.4m in the first half of last year.

Vicon inventory at £9.0m (H1 FY23: £6.4m) is higher than typical due to a planned increase which is largely for operational reasons and is expected to be reduced to around £7.0m by the end of the financial year.

Sense. Analyse. Apply - Five-year plan progress

During the half, we continued to make good progress against our five-year plan, which aims to increase FY21 revenues 2.5x and deliver an adjusted profit before tax margin of 15% by the end of FY26. The plan is all about extending our sensing capabilities, enhancing analysis modes and embedding our IP in other areas. This is being achieved through a measured approach with both organic and inorganic investment.

At our recent Capital Markets Day in April 2024 the progress made through our investment efforts were on display. Now past the halfway point of the five-year plan, we have made clear progress, including:

●Showcasing our markerless technology in action used in Dreamscape's 'The Clockwork Forest' VR experience and seeing how IVS is a great new addition - with positive feedback from those who were able to experience the demos first-hand. To see more on this watch our videos of the day here .
●In November 2023 we acquired IVS, an earnings enhancing acquisition taking us into smart manufacturing, opening up new opportunities for growth and adding even more great names to our strong client roster.
●In August 2023, we unveiled the new markerless technology to extend our sensing capabilities.
●In July 2022, Vicon launched the premium Valkyrie camera to drive organic motion capture growth.
●Successful sale of Yotta to Causeway Technologies for £52m in May 2022 - at a premium valuation that provided a strong cash balance to pursue our growth ambition.

Having started the five-year plan in 2021 with continuing revenues of £27.5m, all from our motion capture business Vicon, we are aiming for £70m revenues by the end of FY26.

Five-year plan investment

Markerless - now a reality

Since unveiling our markerless technology at Siggraph 2023, Vicon has partnered with seven cornerstone customers as part of their Pioneer Program to further develop and test the markerless technology. These cornerstone partners include some of the leading brands in game and film industries and have been carefully selected for their groundbreaking innovations in animation and virtual production. Feedback so far has been encouraging as our teams and partners work hard to commercialise the offering, optimising the future of motion capture and setting the gold standard.

M&A

We continue to actively pursue M&A that aligns with our strict criteria. We are primarily targeting between £3-9m in revenues in smart manufacturing, as we aim to build out from the IVS acquisition. We are actively working on a number of opportunities within the smart manufacturing space that deliver this goal and have discovered a broad and diverse range of opportunities.

Quadrants of growth

Outlook

We enter the second half with a growing sales pipeline well ahead of this time last year and >90% visibility of full year revenues.

We continue to deploy internal and external resources into M&A to deliver on the inorganic component of the five-year strategic plan. Whilst we recognise the Group has considerable cash resources, the Board remain resolute that every acquisition we make will be the right one, for the right reasons and at the right price.

Given the first half performance and visibility of the second half, the Board believe Oxford Metrics are well placed to deliver a performance for the full year in line with current market expectations.

* Profit/(loss) Before Tax from continuing operations before Group recharges adjusted for share-based payments, amortisation of intangibles arising on acquisition and exceptional costs.

CONDENSED CONSOLIDATED INCOME STATEMENT

Six months ended 31 March 2024Six months ended 31 March 2023Year ended 30 September 2023
(unaudited)(unaudited)(audited)
Note£'000£'000£'000
Revenue223,52321,28544,240
Cost of sales(7,806)(7,132)(15,497)
Gross profit15,71714,15328,743
Sales, support and marketing costs(4,531)(3,609)(8,169)
Research and development(2,971)(3,358)(6,599)
Administrative expenses(5,890)(3,671)(8,786)
Operating profit2,3253,5155,189
Finance income1,1995471,561
Finance expense(132)(48)(163)
Profit before taxation3,3924,0146,587
Taxation(598)(648)(611)
Profit from continuing operations2,7943,3665,976
Loss from discontinued operations, net of tax(1,382)(123)(320)
Profit for the period attributable to owners of the parent during the period1,4123,2435,656
Basic earnings per share (pence)62.13p2.59p4.59p
Diluted earnings per share (pence)62.10p2.55p4.56p
Basic earnings per share (pence)61.08p2.49p4.35p
Diluted earnings per share (pence)61.05p2.46p4.32p
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
Six months ended 31 March 2024Six months ended 31 March 2023Year ended 30 September 2023
(unaudited)(unaudited)(audited)
£'000£'000£'000
Net profit for the period1,4123,2435,656

Other comprehensive income

Items that will or may be reclassified to profit or loss

Six months ended 31 March 2024Six months ended 31 March 2023Year ended 30 September 2023
(unaudited)(unaudited)(audited)
Note£'000£'000£'000
Exchange differences on retranslation of overseas subsidiaries(35)(368)(110)
Total other comprehensive expense(35)(368)(110)
Total comprehensive income for the period attributable to the owners of the parent1,3772,8755,546
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
31 March 202431 March 202330 September 2023
(unaudited)(unaudited)(audited)
Note£'000£'000£'000
Non-current assets
Goodwill and intangible assets17,2429,79810,203
Property, plant and equipment3,1911,7912,480
Right of use assets4,1201,8563,135
Financial asset - investments236236236
24,78913,68116,054
Current assets
Inventories9,0326,4157,240
Trade and other receivables8,0198,1219,907
Current tax debtor-63-
Fixed term deposits44,00052,00042,000
Cash and cash equivalents10,75411,61323,965
71,80578,21283,112
Assets classified as held for sale407--
Current liabilities
Trade and other payables(9,217)(8,653)(11,304)
Current tax liability(371)-(275)
Bank overdraft--(1.174)
Lease liabilities(1,214)(407)(724)
(10,802)(9,060)(13,477)
Liabilities directly associated with assets classified as held for sale(70)--
Net current assets61,34069,15269,635
Total assets less current liabilities86,12982,83385,689
Non-current liabilities
Other liabilities(1,302)(1,320)(820)
Lease liabilities(3,177)(1,577)(2,498)
Provisions(52)(44)(48)
Deferred tax liability(1,652)(1,468)(1,118)
(6,183)(4,409)(4,484)
Net assets79,94678,42481,205

Capital and reserves attributable to the owners of the parent

Six months ended 31 March 2024Six months ended 31 March 2023Year ended 30 September 2023
(unaudited)(unaudited)(audited)
Note£'000£'000£'000
Share capital7329325326
Shares to be issued656565
Share premium account19,49419,35519,487
Merger reserve870--
Retained earnings58,34758,06160,451
Foreign currency translation reserve841618876
Total equity shareholders' funds79,94678,42481,205
CONDENSED CONSOLIDATED STATEMENT OF CASHFLOWS
Six months ended 31 March 2024Six months ended 31 March 2023Year ended 30 September 2023
(unaudited)(unaudited)(audited)
£'000£'000£'000
Cash flows from operating activities
Profit for the year1,4123,2435,656
Income tax expense598638594
Finance income(1,199)(547)(1,561)
Finance expense13248163
Depreciation and amortisation1,8621,3802,898
Impairment of intangible assets1,076217217
Profit on sale of property, plant and equipment-(8)(8)
Share based payments666259
Increase in inventories(1,541)(1,976)(2,799)
Decrease/(increase) in receivables2,597(531)(2,274)
(Decrease)/increase in payables(2,509)(2,326)205
Cash generated from operating activities2,4942003,150
Tax (paid)/received(305)179209
Net cash from operating activities2,1893793,359
Cash flows from investing activities
Purchase of property, plant and equipment(969)(467)(1,499)
Purchase of intangible assets(1,420)(868)(2,127)
Proceeds on disposal of property, plant and equipment978
Purchase of fixed asset investments net of cash acquired(6,231)--
Cash placed on fixed term deposit(22,968)(37,000)(67,000)
Fixed term deposits maturing20,96840,00080,000
Interest received6504421,219
Net cash used in investing activities(9,961)2,11410,601
Cash flows from financing activities
Principal paid on lease liabilities(313)(229)(579)
Interest paid on lease liabilities(132)(40)(159)
Interest paid-(8)(4)
Issue of ordinary shares7262370
Equity dividends paid(3,615)(3,246)(3,246)
Net cash used in financing activities(4,053)(3,261)(3,618)
Net (decrease)/increase in cash and cash equivalents(11,825)(768)10,342
Cash and cash equivalents at beginning of the period22,79112,67912,679
Exchange loss on cash and cash equivalents(129)(298)(230)
10,83711,61322,791
Cash and cash equivalents included in current assets10,75411,61323,965
Bank overdraft included in current liabilities--(1,174)
Amount included in assets classified as held for sale83--
10,83711,61322,791
CONDENSED CONSOLIDATED STATEMENT OF CHANGES TO EQUITY
Share CapitalShares to be issuedShare premium accountMerger reserveRetained earningsForeign currency translation reserveTotal
£'000£'000£'000£'000£'000£'000£'000
Balance as at 30 September 20233266519,487-60,45187681,205
Net profit for the period----1,412-1,412
Exchange difference on retranslation of overseas subsidiaries-----(35)(35)
Transactions with owners:
Dividends----(3,615)-(3,615)
Issue of share capital3-7870--880
Share based payment charge----66-66
Balance as at 31 March 20243296519,49487058,34784179,946
Balance as at 30 September 20223246519,094-57,91798678,386
Net profit for the period----3,243-3,243
Exchange differences on retranslation of overseas subsidiaries-----(368)(368)
Transactions with owners:
Dividends----(3,246)-(3,246)
Issue of share capital1-261---262
Share based payment charge----62-62
Balance as at 31 March 20233256519,355-58,06161878,424
Balance as at 30 September 20223246519,094-57,91798678,386
Net profit for the period----5,656-5,656
Exchange differences on retranslation of overseas subsidiaries-----(110)(110)
Transactions with owners:
Dividends----(3,246)-(3,246)
Issue of share capital2-393---395
Share based payment charge----34-34
Balance as at 30 September 20233266519,487-60,45187681,205

The accompanying notes are an integral part of this interim financial information.

NOTES TO THE CONDENSED CONSOLIDATED INTERIM STATEMENTS

Basis of preparation

Oxford Metrics Plc, (the "Company") is a company domiciled in England. The condensed consolidated interim financial statements of the Company for the six months ended 31 March 2024 comprise the Company and its subsidiaries (together referred to as the "Group").

The condensed consolidated interim financial statements have been prepared using accounting policies consistent with those of the annual financial statements for the year ended 30 September 2023. They are in accordance with IAS 34. Other new and amended standards and interpretations issued by the IASB that will apply for the first time in the next annual financial statements are not expected to impact the Group as they are either not relevant to the Group's activities or require accounting which is consistent with the Group's current accounting policies.

The interim financial statements have not been audited or reviewed and the financial information contained in this report does not constitute statutory accounts within the meaning of Section 434 of the Companies Act 2006. The comparative figures for the year ended 30 September 2023 are not the statutory accounts but have been extracted from the Group's 2023 financial statements which have been delivered to the Registrar of Companies. The auditors' report on those financial statements was unqualified did not contain references to any matters to which the auditors drew attention without qualifying the report and did not contain a statement under Section 498(2) or (3) of the Companies Act 2006.

  • Revenue from contracts with customers All revenue shown within note 2 relates to continuing operations.
Six months ended 31 March 2024Six months ended 31 March 2023Year ended 30 September 2023
(unaudited)(unaudited)(audited)
Revenue£'000£'000£'000
Vicon UK11,84113,76525,545
Vicon USA9,9187,52018,695
Vicon Group21,75921,28544,240
Industrial Vision Systems1,764--
Oxford Metrics Group23,52321,28544,240
Six months ended 31 March 2024 (unaudited)
Vicon UKVicon USATotal Vicon GroupIndustrial Vision SystemsTotal Group
£'000£'000£'000£'000£'000
Timing of the transfer of goods and services
Point in time10,8848,34919,233-19,233
Over time9571,5692,5261,7644,290
11,8419,91821,7591,76423,523
Contract Counterparties
Direct to consumers3,8759,33513,2101,76414,974
Third party distributor7,9665838,549-8,549
11,8419,91821,7591,76423,523
By destination
UK1,878-1,8788222,700
Germany1,230-1,230-1,230
Italy263-263-263
Spain51-51172223
Netherlands256-256-256
France234-2343237
Rest of Europe1,566-1,5661351,701
Total Europe3,600-3,6003103,910
Canada36656684801,148
Mexico-1010-10
USA299,1999,22839,231
Rest of North America-224446
Total North America329,8769,90852710,435
Australia9014905-905
Hong Kong545-545-545
Japan2,272-2,272-2,272
Korea552-55211563
China1,481-1,481-1,481
India185-185-185
Rest of Asia Pacific308-30894402
Total Asia Pacific6,24446,2481056,353
Other8738125-125
Oxford Metrics Group11,8419,91821,7591,76423,523
Six months ended 31 March 2023 (unaudited)
Vicon UKVicon USATotal
£'000£'000£'000
Timing of the transfer of goods and services
Point in time12,8836,32219,205
Over time8821,1982,080
13,7657,52021,285
Contract Counterparties
Direct to consumers2,6007,2109,810
Third party distributor11,16531011,475
13,7657,52021,285
By destination
UK1,182-1,182
Germany1,143-1,143
Italy424-424
Greece59-59
Netherlands258-258
France621-621
Spain68-68
Poland105-105
Rest of Europe628-628
Total Europe3,306-3,306
Canada-1,5181,518
USA-5,8895,889
Total North America-7,4077,407
Australia3457352
Hong Kong1,212-1,212
Japan3,896-3,896
Korea1,234-1,234
China2,240-2,240
Rest of Asia Pacific298-298
Total Asia Pacific9,22579,232
Other52106158
Oxford Metrics Group13,7657,52021,285
Year ended 30 September 2023 (audited)
Vicon UKVicon USATotal
£'000£'000£'000
Timing of the transfer of goods and services
Point in time23,71416,03239,746
Over time1,8312,6634,494
Oxford Metrics Group25,54518,69544,240
Contract Counterparties
Direct to consumers5,34117,67323,014
Third party distributor20,2041,02221,226
Oxford Metrics Group25,54518,69544,240
By destination
UK3,176-3,176
Germany1,973-1,973
Italy633-633
Netherlands646-646
France155-155
Poland178-178
Spain88-88
Ireland565-565
Rest of Europe1,087-1,087
Total Europe5,325-5,325
Canada91,8781,887
USA1216,53316,545
Total North America2118,41118,432
Australia93913952
Hong Kong2,517-2,517
Japan5,680-5,680
South Korea2,835-2,835
China3,957-3,957
India574-574
Rest of Asia Pacific397-397
Total Asia Pacific16,8991316,912
Other124271395
Total25,54518,69544,240
Six months ended 31 March 2024Six months ended 31 March 2023Year ended 30 September 2023
(unaudited)(unaudited)(audited)
£'000£'000£'000
Group revenue by market
Engineering4,8553,1018,708
Entertainment8,49411,00118,193
Life sciences8,0515,82014,841
Location based entertainment3591,3632,498
Smart manufacturing1,764--
Total23,52321,28544,240
Group revenue by type
Sale of hardware19,33218,07636,158
Sale of software9171,2691,974
Rendering of services2,6491,5035,209
Support625437899
Total23,52321,28544,240
Group revenue by origin
UK12,91512,90623,690
Europe6908591,852
North America9,9187,52018,695
Asia Pacific--3
Total23,52321,28544,240

Segmental Analysis

Segment information is presented in the condensed consolidated interim financial statements in respect of the Group's business segments, which are reported to the Chief Operating Decision Maker (CODM). The Group has identified the Board of Directors of Oxford Metrics plc, ("the Board") as the CODM. The business segment reporting reflects the Group's management and internal reporting structure.

The Group comprises the following business segments:

Vicon Group: This is the development, production and sale of computer software and equipment for the entertainment, engineering and life science markets; and

Industrial Vision Systems: This is the development, production and sale of smart manufacturing systems.

Other unallocated costs represent head office expenses not recharged to subsidiary companies.

Business segments are analysed below:

Segment depreciation and amortisation

Six months ended 31 March 2024Six months ended 31 March 2023 restatedYear ended 30 September 2023 restated
(unaudited)(unaudited)(audited)
£'000£'000£'000
Continuing operations
Vicon UK1,4561,3362,606
Vicon USA192158341
Vicon Group1,6481,4942,947
Industrial Vision Systems129--
Unallocated112945
Total continuing operations1,7881,5232,992
Adjusted profit/(loss) before taxAdjusting itemsGroup rechargesProfit/(loss) before taxAdjusted profit/(loss) before taxAdjusting itemsGroup rechargesProfit/(loss) before taxAdjusted profit/(loss) before taxAdjusting itemsGroup rechargesProfit/(loss) before tax
£'000£'000£'000£'000£'000£'000£'000£'000£'000£'000£'000£'000
Continuing operations
Vicon UK463(108)1,3841,7392,658(108)8073,3572,648(216)2,1634,595
Vicon USA3,859-(3,685)1742,683-(2,636)476,542-(6,162)380
Vicon Group4,322(108)(2,301)1,9135,341(108)(1,829)3,4049,190(216)(3,999)4,975
Industrial Vision Systems507(37)(152)318
Unallocated(783)(232)2,1761,161(874)(49)1,533610(1,690)(8)3,3101,612
Total4,046(377)(277)3,3924,467(157)(296)4,0147,500(224)(689)6,587
Discontinued operations
Vicon UK - IMU(546)(1,112)277(1,381)(393)(36)296(133)(955)(72)689(338)
Oxford Metrics Group3,500(1,489)-2,0114,074(193)-3,8816,545(296)-6,249
Six months ended 31 March 2024 (unaudited)Six months ended 31 March 2023 (unaudited)Year ended 30 September 2023 (audited)Six months ended 31 March 2024 (unaudited)Six months ended 31 March 2023 (unaudited)Year ended 30 September 2023 (audited)Six months ended 31 March 2024 (unaudited)Six months ended 31 March 2023 (unaudited)Year ended 30 September 2023 (audited)Six months ended 31 March 2024 (unaudited)Six months ended 31 March 2023 (unaudited)Year ended 30 September 2023 (audited)
£'000£'000£'000£'000£'000£'000£'000£'000£'000£'000£'000£'000
Vicon UK13,31312,62312,7633,4381,8283,88528,15631,15428,161(9,789)(9,751)(10,717)
Vicon USA2,7771,4543,010601701,99810,7975,93313,107(5,061)(4,245)(6,116)
Vicon Group16,09014,07715,7733,4981,9985,88338,95337,08741,268(14,850)(13,996)(16,833)
Industrial Vision Systems8,425--6--10,017--(878)--
Unallocated2745812815555554,08361,83563,950(1,327)(450)(1,128)
OMG Life Group*------(6,052)(6,052)(6,052)---
Oxford Metrics Group24,78914,65816,0543,5092,0535,93897,00192,87099,166(17,055)(14,446)(17,961)
4. Reconciliation of adjusted profit before tax
Six months ended 31 March 2024Six months ended 31 March 2023Year ended 30 September 2023
(unaudited)(unaudited)(audited)
£'000£'000£'000
Profit before tax - continuing operations3,3924,0146,587
Share option charges666234
Amortisation of intangibles arising on acquisition13295190
Costs associated with acquisition of Industrial Vision Systems Ltd179--
Reapportion Group overheads277296689
Adjusted profit before tax - continuing operations4,0464,4677,500
Profit before tax - discontinued operations(1,381)(133)(338)
Amortisation of intangibles arising on acquisition363672
Impairment of goodwill1,076--
Reapportion Group overheads(277)(296)(689)
Adjusted profit before tax - discontinued operations(546)(393)(955)
Adjusted profit before tax - total operations3,5004,0746,545
Basic earnings per share (pence)2.63p2.94p5.29p
Diluted earnings per share (pence)2.59p2.91p5.26p

The adjusted profit before tax for the Vicon business segments is shown in detail below;

Vicon Group

Six months ended 31 March 2024Six months ended 31 March 2023Year ended 30 September 2023
(unaudited)(unaudited)(audited)
£'000£'000£'000
Profit before tax - continuing operations1,9133,4044,975
Share option charges131326
Amortisation of intangibles arising on acquisition9595190
Reapportion Group overheads2,3011,8293,999
Adjusted profit before tax - continuing operations4,3225,3419,190

Taxation

The Group's consolidated effective tax rate for the six months ended 31 March 2024 was 29.5% (for the six months ended 31 March 2023: 16.3%; for the year ended 30 September 2023: 9.5%.

In accordance with IAS 34 the tax charge for the half year is calculated on the basis of the estimated full year tax rate.

Earnings per share

The calculation of the basic earnings per share is based on the earnings attributable to ordinary shareholders divided by the weighted average number of shares in issue during the period. The calculation of diluted earnings per share is based on the basic earnings per share, adjusted to allow for the issue of shares on the assumed conversion of all dilutive options.

31 March 2024 (unaudited)31 March 2023 (unaudited)30 September 2023 (audited)
Earnings/(loss)Weighted average number of sharesPer share amountEarnings/(loss)Weighted average number of sharesPer share amountEarnings/(loss)Weighted average number of sharesPer share amount
£'000'000(pence)£'000'000(pence)£'000'000(pence)
Continuing operations
Basic earnings per share
Earnings attributable to ordinary shareholders2,794131,2362.133,367129,9752.595,976130,1624.59
Dilutive effect of employee share options-1,793(0.03)-1,876(0.03)-904(0.03)
Diluted earnings per share2,794133,0292.103,367131,8512.565,976131,0664.56
Discontinued operations
Basic loss per share
Earnings attributable to ordinary shareholders(1,382)131,236(1.05)(124)129,975(0.10)(320)130,162(0.24)
Dilutive effect of employee share options-1,793--1,876--904-
Diluted loss per share(1,382)133,029(1.05)(124)131,851(0.10)(320)131,066(0.24)
Total operations
Basic earnings per share
Loss attributable to ordinary shareholders1,412131,2361.083,243129,9752.495,656130,1624.35
Dilutive effect of employee share options-1,793(0.03)-1,876(0.03)-904(0.03)
Diluted earnings per share1,412133,0291.053,243131,8512.465,656131,0664.32
7. Share capital
31 March31 March30 September
202420232023
(unaudited)(unaudited)(audited)
£'000£'000£'000
Allotted, called up and fully paid
131,439,635 shares of 0.25p (31 March 2023: 130,239,276 shares of 0.25p and 30 September 2023: 130,420,276 shares of 0.25p)329325326

During the six months ended 31 March 2024 there were 12,000 shares issued relating to share options that were exercised. There were 444,000 shares issued in respect of share options exercised during the six months ended 31 March 2023 (year ended 30 September 2023: 625,000).

In addition, during the six months ended 31 March 2024 there were 1,007,000 shares issued as consideration for the acquisition of Industrial Vision Systems Limited.

There were no shares (six months ended 31 March 2023: 27,624 shares) issued to the non-executive Chairman, Roger Parry, in satisfaction of salary.

Dividends

The following dividends were recognised as distributions to equity holders in the period:

31 March31 March30 September
202420232023
(unaudited)(unaudited)(audited)
£'000£'000£'000
Final dividend for 2022 paid in 2023 - 2.50 pence per share-3,2463,246
Final dividend for 2023 paid in 2024 - 2.75 pence per share3,615--
3,6153,2463,246

The final dividend for 2023 was paid to shareholders on 14 February 2024 at 2.75 pence per share, a total of £3,615,000.

Business combinations

The Group acquired 100% of the share capital of Industrial Vision Systems Limited on 31 October 2023 for a total provisional consideration of £8.1m, 10% of which has been funded though the issue of share capital with the balance coming from existing cash resources.

A provisional valuation of the assets acquired and resulting goodwill has been performed and included within these results. Further detail will be provided in the full Annual Report for the year ending 30 September 2024.

Copies of the interim statement

Copies of the interim statement will be available from the Company's registered office at 6 Oxford Pioneer Park, Yarnton, Oxfordshire OX5 1QU, and from the Company's website: www.oxfordmetrics.com.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note